| Literature DB >> 34102100 |
Shihao Xu1, Omkar Chaudhary2, Patricia Rodríguez-Morales1, Xiaoli Sun3, Dan Chen1, Roberta Zappasodi4, Ziyan Xu5, Antonio F M Pinto6, April Williams7, Isabell Schulze4, Yagmur Farsakoglu1, Siva Karthik Varanasi1, Jun Siong Low8, Wenxi Tang3, Haiping Wang9, Bryan McDonald1, Victoria Tripple1, Michael Downes10, Ronald M Evans10, Nada A Abumrad11, Taha Merghoub12, Jedd D Wolchok12, Maxim N Shokhirev7, Ping-Chih Ho9, Joseph L Witztum3, Brinda Emu2, Guoliang Cui13, Susan M Kaech14.
Abstract
A common metabolic alteration in the tumor microenvironment (TME) is lipid accumulation, a feature associated with immune dysfunction. Here, we examined how CD8+ tumor infiltrating lymphocytes (TILs) respond to lipids within the TME. We found elevated concentrations of several classes of lipids in the TME and accumulation of these in CD8+ TILs. Lipid accumulation was associated with increased expression of CD36, a scavenger receptor for oxidized lipids, on CD8+ TILs, which also correlated with progressive T cell dysfunction. Cd36-/- T cells retained effector functions in the TME, as compared to WT counterparts. Mechanistically, CD36 promoted uptake of oxidized low-density lipoproteins (OxLDL) into T cells, and this induced lipid peroxidation and downstream activation of p38 kinase. Inhibition of p38 restored effector T cell functions in vitro, and resolution of lipid peroxidation by overexpression of glutathione peroxidase 4 restored functionalities in CD8+ TILs in vivo. Thus, an oxidized lipid-CD36 axis promotes intratumoral CD8+ T cell dysfunction and serves as a therapeutic avenue for immunotherapies.Entities:
Keywords: CD36; CD8(+) T cells; lipid peroxidation; oxidized lipids; tumor microenvironment
Mesh:
Substances:
Year: 2021 PMID: 34102100 PMCID: PMC9273026 DOI: 10.1016/j.immuni.2021.05.003
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 43.474